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Abstract
Robust advances in interactome analysis demand comprehensive, non-redundant and consistently anno-
tated datasets. By non-redundant, we mean that the accounting of evidence for every interaction should be
faithful: each independent experimental support is counted exactly once, no more, no less. While many in-
teractions are shared among public repositories, none of them contains the complete known interactome for
any model organism. In addition, the annotations of the same experimental result by different repositories
often disagree. This brings up the issue of which annotation to keep while consolidating evidences that are
the same. The iRefIndex database, including interactions from most popular repositories with a standard-
ized protein nomenclature, represents a significant advance in all aspects, especially in comprehensiveness.
However, iRefIndex aims to maintain all information/annotation from original sources and requires users to
perform additional processing to fully achieve the aforementioned goals. Another issue has to do with pro-
tein complexes. Some databases represent experimentally observed complexes as interactions with more than
two participants, while others expand them into binary interactions using spoke or matrix model. To avoid
untested interaction information buildup, it is preferable to replace the expanded protein complexes, either
from spoke or matrix models, with a flat list of complex members.
To address these issues and to achieve our goals, we have developed ppiTrim, a script that processes
iRefIndex to produce non-redundant, consistently annotated datasets of physical interactions. Our script
proceeds in three stages: mapping all interactants to gene identifiers and removing all undesired raw inter-
actions, deflating potentially expanded complexes, and reconciling for each interaction the annotation labels
among different source databases. As an illustration, we have processed the three largest organismal datasets:
yeast, human and fruitfly. While ppiTrim can resolve most apparent conflicts between different labelings, we
also discovered some unresolvable disagreements mostly resulting from different annotation policies among
repositories.
URL: www.ncbi.nlm.nih.gov/CBBresearch/Yu/downloads/ppiTrim.html
Introduction
The current decade has witnessed a significant amount of effort towards discovering the networks of protein-
protein interactions (interactomes) in a number of model organisms. These efforts resulted in hundreds of
thousands of individual interactions between pairs of proteins being reported (1). Repositories such as the
BioGRID (2), IntAct (3), MINT (4), DIP (5), BIND (6, 7) and HPRD (8) have been established to store
and distribute sets of interactions collected from high-throughput scans as well as from curation of individual
publications. Depending on its goals, each interaction database, maintained by a different team of curators
located around the world includes and annotates interactions differently. Consequently, while many interactions
of specific interactomes are shared among databases (1, 9), no one contains the complete known interactome
for any model organism. Constructing a full-coverage protein-protein interaction network therefore requires
retrieving and combining entries from many databases.
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This task is facilitated by several initiatives developed by the proteomics community over the years. The
IMEx consortium (10) was formed to facilitate interchange of information between different primary databases
by using a standardized format. The Proteomics Standards Initiative Molecular Interaction (PSI-MI) for-
mat (11) allows a standard way to represent protein interaction information. One of its salient features is
the controlled vocabulary of terms that can be used to describe various facets of a protein-protein interaction
including source database, interaction detection method, cellular and experimental roles of interacting proteins
and others. The PSI-MI vocabulary is organized as an ontology, a directed acyclic graph (DAG), where nodes
correspond to terms and links to relations between terms. This enables the terms to be related in an efficient
and algorithm-friendly manner.
Consistently annotated datasets are useful for development and assessment of interaction prediction tools (12,
13, 14, 15). Furthermore, such datasets also form the basis of interaction networks, for which numerous anal-
ysis tools have been developed (16, 17). Depending on biological aims of a tool, different entities (nodes) and
potentially weighted interactions (edges) may be preferred. The chance of conflicting predictions from differ-
ent tools can be reduced by starting from a consistently annotated dataset that faithfully represents all available
evidences. Such dataset ought to be comprehensive but also non-redundant: the same experimental evidence
for an interaction should appear once and only once. To maintain a coherent development of biological under-
standing, it is indispensable to keep the reference datasets up-to-date.
We examined several primary interaction databases with the aim of constructing non-redundant (in terms of
evidence), consistently annotated and up-to-date reference datasets of physical interactions for several model
organisms. Unfortunately, the common standard format used by most primary databases still does not allow
direct compilation of full non-redundant interactomes. This mainly results from the fact that different primary
databases may use different identifiers for interacting proteins and different conventions for representing and
annotating each interaction. Combining interaction data from BIND (6, 7) (in two versions called ‘BIND’ and
‘BIND Translation’), BioGRID (2), CORUM (18), DIP (5), HPRD (8), IntAct (3), MINT (4), MPact (19),
MPPI (20) and OPHID (21), the iRefIndex (22) database represents a significant advance towards a complete
and consistent set of all publicly available protein interactions. Apart from being comprehensive and relatively
up-to-date, the main contribution of iRefIndex is in addressing the problem of protein identifiers by mapping
the sequence of every interactant into a unique identifier that can be used to compare interactants from different
source databases. In a further ‘canonicalization’ procedure (23), different isoforms of the same protein are
mapped to the same canonical identifier. By adhering to the PSI-MI vocabulary and file format, iRefIndex
provides largely standardized annotations for interactants and interactions. Construction of iRefIndex led to
the development of iRefWeb, a web interface for interactive access to iRefIndex data (23). iRefWeb allows an
easy visualization of evidence for interactions associated with user-selected proteins or publications. Recently,
the authors of iRefIndex and iRefWeb published a detailed analysis of agreement between curated interactions
within iRefIndex that are shared between major databases (24).
However, aiming to maintain all information from original sources, iRefIndex requires users to perform
additional processing to fully achieve the aforementioned goals. In particular, iRefIndex considers redundancy
in terms of (unordered) pairs of interactants rather than in terms of experimental evidence associated with an
interaction. Consequently, there will be features one desires to have that may not fit well within the scope of
iRefIndex. For example, one may wish to treat interactions arising from enzymatic reactions as directed and to
be able to selectively include/exclude certain types of reactions such as acetylation. In many cases, the infor-
mation about post-translational modifications is available directly from source databases, but is not integrated
into iRefIndex. Another issue that propagates into iRefIndex from source databases has to do with protein
complexes. Some databases represent experimentally observed complexes as interactions with more than two
participants, while others expand them into binary interactions using spoke or matrix model (1). Turinsky et al.
(24) recently observed that this different representation of complexes is responsible for a significant number of
disagreements between major databases curating the same publication. From our earlier work (25), we found
that such expanded complexes may lead to nodes with very high degree and often introduce undesirable short-
cuts in networks. To fairly treat the information provided by protein complexes without exaggeration, it is
preferable to replace the expanded interactions, either from spoke or matrix models, with a flat list of complex
members. Additionally, we discovered that the mapping of each protein to a canonical group by iRefIndex
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would sometimes place protein sequences clearly originating from the same gene (for example differing in one
or two amino acids) into different canonical groups.
To achieve the goal of constructing non-redundant, consistently annotated and up-to-date reference datasets,
we developed a script, called ppiTrim, that processes iRefIndex and produces a consolidated dataset of physical
protein-protein interactions within a single organism.
Materials and Methods
Our script, called ppiTrim, is written in the Python programming language. It takes as input a dataset in
iRefIndex PSI-MI TAB 2.6 format, with 54 TAB-delimited columns (36 standard and 18 added by iRefIndex).
After three major processing steps, it outputs a consolidated dataset, in PSI-MI TAB 2.6 format, containing only
the 36 standard columns (Supplementary Table 1). The three processing steps are: (i) mapping all interactants
to NCBI Gene IDs and removing all undesired raw interactions; (ii) deflating potentially expanded complexes;
and (iii) collecting all raw interactions, originated from a single publication, that have the same interactants and
compatible experimental detection method annotations into one consolidated interaction. At each step, ppiTrim
downloads the files it requires from the public repositories and writes its intermediate results as temporary files.
Phase I: initial filtering and mapping interactants
In Phase I, ppiTrim takes the original iRefIndex dataset and classifies each raw interaction (either a binary
interaction corresponding to a single line in the input file or a complex supported by several lines) into one of
four distinct categories: removed (not examined further), biochemical reaction, complex or potentially part of
a complex, and other (direct binary binding interaction). It removes interactions marked as genetic, originating
from publications specified through a command line parameter or having interactants from organisms other
than the main species of the input dataset (the allowed species can be explicitly provided or any interaction with
interactants having different Taxonomy IDs is removed). Additionally, ppiTrim removes all interactions from
OPHID and the ‘original’ BIND. The former is removed because it contains either computationally predicted
interactions or interactions verified from the literature using text mining (i.e. without human curation). The
latter is removed because it processes the same original dataset as BIND Translation (7).
As a first step, the script seeks to map each interactant to an NCBI Entrez Gene (26) identifier. For
most interactants, it uses the mapping already provided by iRefIndex. In the cases where iRefIndex pro-
vides only a Uniprot (27) knowledge base accession, the script attempts to obtain a Gene ID in three different
ways. First, it searches the iRefIndex mappings.txt file (found compressed in ftp.no.embnet.org/
irefindex/data/current/Mappingfiles/ for any additional mappings. This part is optional be-
cause the mappings.txt file is very large even compressed and it would not be feasible to perform auto-
matic download each time ppiTrim is run. Second, for all unmapped Uniprot IDs, it retrieves the corresponding
full Uniprot records using the dbfetch tool from EBI (www.ebi.ac.uk/Tools/dbfetch). If a direct
mapping to Gene ID is present within the record as a part of DR field, it is used. Otherwise, the canonical gene
name (field GN) is used to query the NCBI Entrez Gene database for a matching Gene record using an Eutils
interface. If a single unambiguous match is found, the record’s Gene ID is used for the interactant. No mapping
is performed if multiple matches are obtained. Every mapped Gene ID is checked against the list of obsolete
Gene IDs, which are no longer considered to have a protein product existing in vivo. The interactants that can-
not be mapped to valid (non-obsolete) Gene IDs are removed along with all raw interactions they participate
in.
After assigning Gene IDs, the script considers the PSI-MI ontology terms associated with interaction de-
tection method, interaction type and interactants’ biological roles. Using the full PSI-MI ontology file in Open
Biomedical Ontology (OBO) format (28), it replaces any non-standard terms in these fields (labeled MI:0000)
with the corresponding valid PSI-MI ontology terms. The terms marked as obsolete in the PSI-MI OBO file
are exchanged for their recommended replacements (Supplementary Table 2). The single exception are the
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interaction detection method terms for HPRD ‘in vitro’ (MI:0492, translated from MI:0045 label in iRefIndex)
and ‘in vivo’ (MI:0493) interactions, which are kept throughout the entire processing.
Source interactions annotated with a descendant of the term MI:0415 (enzymatic study) as their detection
method or with a descendant of the term MI:0414 (enzymatic reaction) as their interaction type are classified as
candidate biochemical reactions. This category also includes any interactions (including those with more than
two interactants) where one of interactants has a biological role of MI:0501 (enzyme) or MI:0502 (enzyme
target). In the recent months, the BioGRID database has started to provide additional information about the
post-translational modifications associated with the ‘biochemical activity’ interactions, such as phosphoryla-
tion, ubiquitination etc. This information is available from the BioGRID datasets in the new TAB2 format but
is not yet reflected in the PSI-MI terms for interaction type provided in the PSI-MI 2.5 format or in iRefIndex.
Since the post-translational modifications annotated by the BioGRID can be directly matched to standard PSI-
MI terms (Supplementary Table 3), the script downloads the most recent BioGRID dataset in TAB2 format,
extracts this information and assigns appropriate PSI-MI terms for interaction type to the candidate biochemical
reactions from iRefIndex that originate from the BioGRID.
Any source interaction not classified as candidate biochemical reaction is considered for assignment to
the candidate complex categories. This category includes all true complexes (having edge type ‘C’ in iRe-
fIndex), interactions having a descendant of MI:0004 (affinity chromatography) as the detection method term
or MI:0403 (colocalization) as the interaction type, as well as the interactions corresponding to the BioGRID’s
‘Co-purification’ category. Interactions with interaction type MI:0407 (direct interaction) are never considered
candidates for complexes. All source interactions not falling into candidate biochemical reaction or candidate
complex categories are considered ordinary binary physical interactions.
Phase II: deflating spoke-expanded complexes
The Phase II script attempts to detect spoke-expanded complexes from ‘candidate complex’ interactions and
deflate them into interactions with multiple interactants. First, all candidate interactions are grouped accord-
ing to their publication (Pubmed ID), source database, detection method and interaction type. Each group of
source interactions is turned into a graph and considered separately for consolidation into one or more com-
plexes. When a portion of a group of interactions is deflated, we replace these source interactions by a complex
containing all their participants. Each collapsed complex is represented using bipartite representation in the
output MITAB file (the same as the original complexes from iRefIndex, but using newly generated complex
IDs) and the references to the original source interactions are preserved (Supplementary Table 1). Two proce-
dures are used for consolidation: pattern detection and template matching (Fig. 1). The deflation algorithm for
each new complex is indicated in the output file through its edge type (Table 1).
Pattern detection procedure is used only for the interactions from the BioGRID. Unlike the interactions
from the DIP, those interactions are inherently directed since one protein is always labeled as bait and other
as prey (in many cases this labeling is unrelated to the actual experimental roles of the proteins). The pattern
indicating a possible spoke-expanded complex consists of a single bait being linked to many preys. Since all
interactions in the BioGRID’s ’Co-purification’ and ’Co-fractionation’ categories arise from complexes that are
spoke-expanded using an arbitrary protein as a bait (BioGRID Administration Team, private communication),
a bait linked to two or more preys can in that case always be considered an expanded complex and deflated.
Such deflated complexes are assigned the edge type code ‘G’. The remainder of the complex candidate inter-
actions from the BioGRID were obtained by affinity chromatography and are, in most cases, also derived from
complexes. Here we adopted a heuristic that a bait linked to at least three preys can be considered a complex.
Clearly, some experiments involve a single bait being used with many independent preys, in which case this
procedure would generate a false complex. Therefore, complexes generated in this way are assigned a different
edge type code (‘A’) and the user is able to specify specific publications to be excluded from consideration as
well as the maximal size of the complex.
The second procedure is based on matching each group of candidate interactions to the complexes indicated
by other databases (templates), mostly from IntAct, MINT, DIP and BIND. In this case, the script checks for
each protein in the group whether it, together with all its neighbors, is a superset of a template complex. If so,
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Figure 1: ppiTrim uses two procedures for complex deflation: pattern detection (top) and template matching (bottom). As an example,
assume that a graph ABCDEFG, shown on the left, could be constructed from complex candidate interactions annotated by the BioGRID
from a single publication. The arrows indicate bait to prey relationships, with the interaction A–D being repeated twice, once with A and
once with D as a bait. Pattern detection algorithm (top) would recognize A and D as hubs of potentially spoke-expanded complexes and
thus replace all pairwise interactions on the left with complexes ABCDEF and ACDEFG. Suppose that the complex ACDEF was reported
from the same publication by a different database. Then, template matching procedure (bottom) would generate the complex ACDEF (with
all other annotation, such as experimental detection method, retained from the original interactions) and remove all original interactions
except D–G and A–B. After performing both procedures, ppiTrim consolidates the results so that the overall result would be replacing the
original interactions by complexes ACDEF, ABCDEF and ACDEFG with edge type codes ‘R’, ‘A’ and ‘A’, respectively. The interactions
A–B and D–G would not be retained since they are contained within the deflated complexes ABCDEF and ACDEFG.
all the candidate interactions between the proteins within the complex are deflated. The neighborhood graph is
undirected for all source databases except the BioGRID. The new complexes generated in this way are given
the code ‘R’. The scripts also attempts to use complexes generated from the BioGRID’s interactions through a
pattern detection procedure as templates, in which case the newly generated complexes have the code ‘N’. Any
source interactions that cannot be deflated into complexes are retained for Phase III.
Phase III: Normalizing interaction type annotation
Overview
The goal of the final phase of ppiTrim is to consolidate all evidence for an interaction, obtained from a single
experiment, into one consolidated interaction record. Every source publication contains descriptions of one or
more experiments that result in reported interactions. Unfortunately, distinct experiments within each publi-
cation are not annotated in all source databases, with the exception of the interactions from IntAct and MINT
that appear to distinguish experiments using a numbered suffix to the author’s name in the ‘Author’ field. It is
therefore necessary to rely on the experimental detection method terms to determine whether source records
from different databases, with the same interactants and source publication, represent the evidence for the same
interaction. Ideally, all such records with the same detection method can be collapsed into one consolidated
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Table 1: Edge type codes used by ppiTrim
Code Description
X undirected binary interaction (physical binding)
D directed binary interaction (biochemical reaction)
B biochemical reaction without indication of directionality
C original complex (from iRefIndex)
G spoke-expanded complex; deflated by pattern matching from BioGRID’s ’Co-purification’ and ’Co-fractionation’
categories (reliable)
R potential spoke-expanded complex; deflated by template matching of a ‘C’-complex
A potential spoke-expanded complex (BioGRID only); deflated by pattern detection
N potential spoke-expanded complex; deflated by template matching of a ‘G’- or ‘A’-complex
interaction, although this may undercount multiple evidences from the same publication obtained by distinct
experiments. However, different databases have different annotation policies and do not necessarily use the
same PSI-MI term to annotate a given experimental method. To resolve detection method term disagreements,
we use the PSI-MI ontology structure (Fig. 2). Two compatible terms assigned by different source databases
are considered to represent the same experimental method within a publication. These annotated records are
thus consolidated.
The Phase III algorithm proceeds as follows. All source interactions and complexes (original as well as
deflated in Phase II) are divided into ‘clusters’. Interactions that share the same interactants and the source
publication are placed into the same cluster. The order of interactants is significant only for biochemical
reactions, which are treated as directed interactions (only when direction can be ascertained). Each cluster is
processed independently and divided into subclusters based on compatibility of the PSI-MI terms for interaction
detection method. Interactions from each subcluster are collected into a single consolidated interaction, which
is output to the final dataset. The consolidated record preserves references to all original interactions. Each
consolidated interaction is assigned a single PSI-MI term for interaction detection method that most specifically
describes the entire collection of annotation terms within the subcluster. For easier reference, each consolidated
interaction is given a unique ppiTrim ID, which is similar to RIGID from iRefIndex. This is a SHA1 hash of
a dot-separated concatenation of its interactants (Gene IDs), publication(s), detection method, interaction type
and edge type. Every complex uses its ppiTrim ID as its primary ID.
Reconciling annotation
The DAG structure of an ontology naturally induces a partial order between the terms: for two terms u
and v, we say that u refines v (u is smaller v, u precedes v) if there exists a directed path in the DAG from
u to v. Two PSI-MI terms can be considered compatible if they are comparable, that is, one refines the other.
Every nonempty collection of terms U can be uniquely split into disjoint sets Ui, such that every Ui has a
single maximal element (an element comparable to and not smaller than any other member) and contains all
members of U comparable to its maximal element. Every subcollection Ui is then consistent because there
exists at least one term within it that can describe all its members, while any two members from different
subcollections are incomparable. The finest consistent term of a subcollection Ui is the smallest member of Ui
that is comparable to all its members (it can also be defined as the smallest member of the intersection of the
transitive closures of all the members of Ui.). If Ui is a total order, where all members are pairwise comparable,
the finest consistent term is the minimal term. On the other hand, the minimal term need not exist (Fig. 2), so
that the finest consistent term is higher in the hierarchy and represents the most specific annotation that can be
assigned to Ui as a whole.
To produce consolidated interactions from a single cluster, each of its members (interactions) is identified
with its PSI-MI term for information detection method. For every cluster member, the set of all other members
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with compatible annotations (‘compatible set’) is computed. As a special case, the following detection method
tags are treated as smaller than any other: ‘unspecified method’ (MI:0686), ‘in vivo’ and ‘in vitro’ (The latter
two are from HPRD only). In this way, non-specific annotations are considered as compatible with all other,
more specific evidences. Compatible sets are further grouped according to their maximal elements. Within each
group, the union of the compatible sets produces a subcluster. The finest consistent term for each subcluster is
found by considering all PSI-MI terms on the paths from the subcluster members to its maximum – the search
is not restricted to those terms that are within the subcluster (Fig. 2).
Conflicts
We consider two subclusters of the same cluster to be in an unresolvable conflict if there is no source
database shared between them. This definition takes into account that a source database may report an inter-
action several times for the same publication, using the same or different interaction detection method. If two
databases annotate the same interaction using incompatible terms, this is most likely due to an error or spe-
cific disagreement about the appropriate label, rather than that each database is reporting a different experiment
from the same publication. Unresolvably conflicting interaction records, after consolidation, point to each other
using ppiTrim ID in the ‘Confidence’ field.
ppiTrim also collects statistics about resolvable conflicts in its temporary output files. A resolvable conflict
is the case where source interactions within a single subcluster have compatible but different experimental
detection method labels.
Figure 2: The picture shows a part of the PSI-MI ontology graph for interaction detection method associated with a hypothetical cluster
of source interactions involving the same interactants from the same publication. The terms colored blue are associated with the source
interactions within the cluster, while those marked yellow and green are present in the ontology but do not label any source interaction from
the cluster. The entire cluster as shown is consistent, with the term MI:0401 as the maximal element. Its finest consistent term is MI:0004
(colored green) since the cluster members smaller than it are not comparable between themselves. Removing the source interactions
labeled by MI:0401 from the cluster would result in three distinct subclusters. If two subclusters contain no interaction from the same
source database, they would be reported as conflicts.
7
Table 2: Processing source interactions
Species Initial Removed Without Gene ID Retained With Mapped Gene ID
S. cerevisiae 400449 173815 3608 223026 880
H. sapiens 382094 148724 2738 230632 16187
D. melanogaster 154770 32477 9476 112817 3427
Statistics of initial processing of raw interactions from iRefIndex. Shown are the initial number, total number removed due to filtering
criteria, number removed due to missing Gene ID, total number of retained and the number retained containing at least one interactant with
mapped Gene ID.
Table 3: Mapping CROGID identifiers from iRefIndex into Gene IDs
Species Initial CROGIDs Aditional Mapped Finaltotal mapped orphans total valid CROGIDs Gene IDs
S. cerevisiae 6159 5552 607 433 47 5599 5618
H. sapiens 14047 11432 2615 1261 1261 12693 11786
D. melanogaster 9379 7810 1569 566 566 8346 7846
Statistics of mapping CROGIDs into Gene IDs. Columns 2-4 show the total number of CROGIDs considered, the number that could be
directly mapped to GeneIDs and the number of ‘orphans’ that are not associated with a Gene ID in the iRefIndex file. Columns 5 and 6
show the numbers of CROGIDs additionally mapped to GeneIDs, while the last two columns show the final number of CROGIDs accepted
and the corresponding number of Gene IDs. It is possible for a CROGID to map to multiple Gene IDs (if multiple genes encode the same
protein sequence) as well as for multiple CROGIDs to map to a single GeneID (if our additional mapping links them to the same gene).
Evaluation of the script
To test ppiTrim, we applied it to the yeast (S. cerevisiae), human (H. sapiens) and fruitfly (D. melanogaster)
datasets from iRefIndex release 8.0-beta, dated Jan 19th 2011. The script was run on June 13th 2011 and used
the then-current versions of Uniprot and NCBI Gene databases. We restricted protein interactors to allowed
NCBI Taxonomy IDs: 4932 and 559292 for yeast, 9606 for human, and 7227 for fruitfly datasets. When
processing the yeast dataset, we accounted for two special cases. First, we specifically removed the genetic
interactions reported by Tong et al. (29) because they were not labeled as genetic for all source databases.
Second, we excluded the dataset by Collins et al. (30) from Phase II and retained all its interactions as binary
undirected. This dataset is present only in the BioGRID and can be considered computationally derived and
partially redundant. Collins et al. (30) reprocessed the data from Gavin et al. (31) and Krogan et al. (32) to
obtain an improved set of pairwise interactions. Collins et al. (30) used hierarchical clustering to recover protein
complexes, but these are not present in the BioGRID. In spite of its redundancy, we decided not to entirely
remove this dataset but also not to attempt to deflate its potential complexes because bait/prey assignments may
not be meaningful in this case.
Results and Discussion
The results of applying ppiTrim to process iRefIndex 8.0 are shown in Tables 2 – 5. The statistics of ID mapping
(Tables 2 and 3) show that a considerable number of interactants could be additionally mapped to Gene ID in
human and fruitfly datasets, thus enabling us to take into consideration a few thousand of raw interactions that
would otherwise be filtered. This is also evident in terms of iRefIndex RIGIDs (Supplementary Table 4), which
associate all raw interactions with interactants with same sequences to a single record. For yeast, the number
of interactions gained by mapping to Gene IDs is small because most of mapped IDs were not valid.
We chose to standardize proteins using NCBI Gene identifiers rather than the iRefIndex-provided canonical
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Table 4: Deflating spoke-expanded complexes
Species Publications Pairs Complexesinitial remaining C G R A N
S. cerevisiae 3924 118819 28643 7729 323 5384 3190 1311
H. sapiens 10317 56111 35650 8382 181 1143 1443 304
D. melanogaster 398 1722 1053 220 16 82 33 3
Shown are the numbers of complexes obtained by deflating binary interactions with affinity chromatography (or related) as experimental
method. Types of complexes are indicated by one letter codes described in Table 1. The counts of pairs shown include those from
publications with fewer than three interactions (per database), which could never be deflated into complexes.
IDs (CROGIDs) for several reasons. NCBI Gene records not only associate each gene with a set of reference
sequences, but also include a wealth of additional data (e.g. list of synonyms) and links to other databases
such as Gene Ontology (33) that are important when using the interaction dataset in practice. In addition, Gene
records are regularly updated and their status evaluated based on new evidence. Thus, a gene record may be
split into several new records or marked as obsolete if it corresponds to an ORF that is known not to produce
a protein. For network analysis applications, it is desirable that only the proteins actually expressed in the
cell are represented in the network and hence the gene status provided by NCBI Gene is a valuable filtering
criterion. Our results in yeast (Table 3) support this premise: most CROGIDs without Gene ID are associated
with sequences derived from ORFs that were subsequently declassified as genes. However, CROGIDs do have
one advantage over NCBI Gene IDs in that they are protein-based and hence identical protein products of
several genes (like histones) are clustered together.
There are several reasons that our algorithm was able to introduce many additional associations of CROGIDs
to Gene IDs. First, iRefIndex only provides mappings to Gene IDs for interactors that have a sequence that
exactly matches a sequence in an NCBI RefSeq record (Ian Donaldson, private communication). By a case-
by-case examination of some orphaned yeast sequences that could be mapped to Gene ID, we found that they
were orphans because they differed in one or two amino acids from that protein’s reference representative
in RefSeq but were not clustered with that representative’s Gene record. Additional mappings can be found
through database cross-reference from a Uniprot record pointing to a Gene ID. The iRefIndex canonicaliza-
tion procedure captures some of these associations in the mappings.txt file but they are not available in
the main iRefIndex MITAB files. We have found (Supplementary Table 5) that some CROGIDs (mostly in
human) can be additionally mapped by using this information in the mappings.txt file. Notably, ppiTrim
accesses a more recent version of Uniprot then iRefIndex and is thus able to find more mappings by accessing
Uniprot cross-references directly. Finally, there is a substantial number of Uniprot records that do not have a
cross-reference to NCBI Gene but can be linked to a Gene record through their canonical gene names. This
last approach can be suggested as an improvement for iRefIndex canonicalization processing.
Around 10% of CROGIDs could not be mapped to Gene IDs even after processing with ppiTrim algo-
rithms. A few interactors (Supplementary Table 5) have only PDB accessions as their primary IDs since their
interactions were derived from crystal structures. In such cases, often only partial sequences of participating
proteins are available. These partial sequences cannot be fully matched to any Uniprot or RefSeq record and
hence are assigned a separate ID. Hence, an improvement for our procedure, that would account for this case as
well as for those unmapped proteins that differ from canonical sequences only by few amino acids, would be to
use direct sequence comparison to find the closest valid reference sequence. This task may not be technically
difficult (a similar procedure was applied by Alves et al. (34) to construct protein databases for mass spectrom-
etry data analysis) but is beyond the scope of ppiTrim, which is intended as a relatively short standalone script.
In our opinion, such additional mappings would best be performed at the level of reference sequence databases
such as Uniprot or RefSeq, which contain curator expertise to resolve ambiguous cases.
Protein complexes obtained through chromatography techniques provide information complementary to
direct binary interactions. While it is often difficult to determine the exact layout of within-complex pairwise
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interactions, an identification of an association of several proteins using mass spectroscopy is an evidence for
in vivo existence of that association. Unfortunately, in spite of its great importance, the currently available
information within iRefIndex is deficient because of different treatments of complexes by different source
databases. Our results (Table 4) show that the apparently inflated complexity of interaction datasets can be
substantially reduced by attempting to collapse spoke-expanded complexes. For yeast, this results in almost
three quarters reduction of the number of candidate interactions. The majority of new complexes falls into
‘G’ and ‘R’ categories, which can be considered most reliable. For the human dataset, reduction is small as a
proportion although in absolute terms the number of new complexes is over 3000. The fruitfly dataset did not
contain many candidate interactions or complexes and hence not many new complexes were obtained.
In general, it is difficult to assess whether newly generated complexes from ‘A’ and ‘N’ categories are
biologically justified, that is, whether they represent a functional entity. If a bait and its preys genuinely
originate from a single experiment, they definitely form a physical association that may be a part of or an
entire functional complex. Since ppiTrim preserves the experimental role labels and the original interaction
identifiers, little information is lost by deflating such associations into a single record. On the other hand, for
some publications, especially those involving experiments with ubiquitin-like proteins as bait, each bait-prey
association may represent a separate experiment and it does not substantiate that different prey proteins may be
co-present in the cell. For example, BioGRID provides 158 physical associations from the paper by Hannich
et al. (35), each involving the yeast Smt3p (SUMO, a ubiquitin-like) protein as a bait. In this case, it is not true
that all the involved preys together form a large complex with the bait. ppiTrim avoids this particular case by
not deflating potentially too large complexes (the maximum deflated complex size is tunable by the user with
the default of 120 proteins), but one can assume that some of deflated ‘complexes’ do not exist in vivo.
To more closely investigate the fidelity of generated complexes, we randomly sampled 25 ‘A’ and ‘N’ de-
flated yeast complexes from the final output of ppiTrim and examined their original publications. Out of these
25 complexes, 15 originated from high-throughput publications (mostly Gavin et al. (31) and Krogan et al.
(32) – Supplementary Table 6), while 10 came from small experiments (Supplementary Table 7). In all high-
throughput cases, the deflated complex represents a true experimental association. In the cases when authors
present their own derived complexes, which in many cases can be found separately under the ‘C’ category, our
deflated complexes form parts of larger derived complexes. Indeed, such derived complexes are obtained by
assembling the results of several bait-prey experiments, each of which forms a single deflated complex. The re-
sults are more varied for low-throughput publications. In most cases, deflated complexes clearly correspond to
functional complexes, although it is sometimes difficult to fully relate author’s conclusions with their reported
results. In two cases, the inferred association is incorrect due to curation errors in the original database. We
have also found a single case where the publication authors directly state that proteins in a deflated complex do
not form a stable complex.
While our sample is extremely small, it does indicate several issues arising from deflation of bait-prey
relationships. In most cases, deflated complexes form parts of what are believed to be functional complexes. It
appears that curation errors or ambiguities may be a more significant source of wrongly inferred associations
than our main assumption that a bait with several preys in a single publication represents a single unit. Overall,
we feel that the benefits from reduction of interactome complexity outweigh the disadvantages from potentially
over deflating interactions. The best way to solve the problem of different representations of protein complexes
would be at the level of source databases (BioGRID in particular), by reexamining the original publications.
Our complexes from the ‘R’ category, where deflated complexes fully agree with an annotated complex from a
different database, could serve as a guide in this case.
Overall, our processing significantly reduced the number of interactions within each of the three datasets
considered (Table 5). This indicates a significant redundancy, particularly for protein complexes, original and
deflated (compare Table 4 with Table 5), and for binary interactions. The directed interactions (biochemical
reactions) are relatively rarer and largely non-redundant at this stage. Given their importance in elucidating
biological function, the directed interactions are expected to be discovered more fully with time. However, one
should note that PSI-MI format can only represent a static relationship among a set of physical entities involved
in the same event, but cannot actually represent two sides of a reaction e.g. A+B → C +D. Certain pairs of
PSI-MI biological role terms can be combined to represent interaction direction e.g. enzyme and enzyme target,
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Table 5: Final consolidated datasets
Species Publications Input Pairs Consolidated Conflictsbiochem other complexes directed undirected resolvable unresolvable
S. cerevisiae 6303 5780 119329 10778 5525 63648 19344 454
H. sapiens 22660 2446 199094 6483 2042 85480 26478 1333
D. melanogaster 564 51 111862 227 33 27981 19430 11
For each species, shown are the numbers of input pairs (input complexes are those from Table 4), classified as either biochemical reactions
(potentially directed) or others; also shown are the final numbers of consolidated interactions (classified as complexes, directed or undi-
rected). The ‘other’ column accounts only for those interactions that were not deflated into complexes in Phase II. The last two columns
show the total numbers of resolvable and unresolvable conflicts between consolidated interactions. An unresolvable conflict is an instance
where two consolidated interactions, originated from the same publication, are reported using incompatible experimental detection method
labels by different databases. A resolvable conflict is the case where source interactions within a single consolidated interaction have
different (but compatible) experimental detection method labels.
Table 6: Most common interaction detection method PSI-MI term conflicts
Term A Sources A Term B Sources B Counts
MI:0007 (anti tag coimmunoprecipitation) M MI:0676 (tandem affinity purification) DI 132
MI:0004 (affinity chromatography) B MI:0363 (inferred by author) I 60
MI:0018 (two hybrid) DIMN MI:0096 (pull down) BI 43
MI:0071 (molecular sieving) DIN MI:0096 (pull down) B 32
MI:0030 (cross-linking study) DIMN MI:0096 (pull down) B 22
MI:0007 (anti tag coimmunoprecipitation) IM MI:0676 (tandem affinity purification) DI 1227
MI:0018 (two hybrid) BDHIM MI:0096 (pull down) BM 17
MI:0096 (pull down) B MI:0107 (surface plasmon resonance) DM 6
MI:0008 (array technology) I MI:0049 (filter binding) M 5
MI:0019 (coimmunoprecipitation) IM MI:0096 (pull down) BI 5
Top five most common interaction detection method PSI-MI term unresolvable conflicts for yeast (top) and human (bottom) datasets are
shown. Source databases are indicated by one letter codes B (BioGRID), D (DIP), I (IntAct), H (HPRD), M (MINT), P (MPPI).
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but these are weak compared to the rich ways that pathway databases like Reactome (36) represent events.
To demonstrate the utility of our conflict resolution method, we present the counts for resolvable and unre-
solvable conflicts in Table 5. Resolvable conflicts significantly outnumber the unresolvable ones. Examining
the most common examples of resolvable conflicts (Supplementary Table 8), one can see that a majority of
them indeed represent the same experiment. Possible exceptions are human interactions annotated by HPRD,
which have ambiguous detection method labels. To address this and similar problems, ppiTrim provides the
maxsources confidence score (Supplementary Table 1), which is an estimate of the maximal number of inde-
pendent experiments contributing to a consolidated interaction. An interesting example of a resolvable conflict
in Supplementary Table 8 is the 444 instances of a consolidated interaction containing source interactions with
detection method labels MI:0004 (affinity chromatography technology), MI:0007 (anti tag coimmunoprecipi-
tation), and MI:0676 (tandem affinity purification). This case is very similar to the one described in Figure 2:
the last two terms are incompatible but the first resolves the conflict as the finest consistent term.
Upon closer examination of the few unresolvable conflicts (Table 6), it can be seen that most common
conflicts arise as instances of few specific labeling disagreements between databases. In many cases, such
disagreements arise from using different sub-terms of affinity chromatography (see Fig. 2) and can be resolved
by assigning a more general term consistent with both conflicting terms. In many other cases, the conflicts are
due to BioGRID internally using a more restricted detection method vocabulary than the IMEx databases (DIP,
IntAct and MINT). However, in some rare cases, an unresolvable conflict arises when different databases an-
notate different experiments from the same publication. For example, each of DIP, BioGRID and IntAct report
several raw interactions from the paper by Blaiseau and Thomas (37) (pubmed:9799240), where yeast Met4p
protein interacts with each of Met28p, Met31p and Met32p in binary interactions. The paper reports several ex-
periments using different techniques including northern blotting, yeast two hybrid and electrophoretic mobility
shift assays. For the interaction between Met4p and Met28p, BioGRID and IntAct report only MI:0018 (yeast
two hybrid) method, while DIP reports only MI:0404 (comigration in non denaturing gel electrophoresis), re-
sulting in unresolvable conflict. Hence, in this case, each database on its own provides incomplete evidence for
this interaction.
The ppiTrim algorithms work best if accurate and fully populated fields for interaction detection method,
publication and interaction type are available in its input dataset. This requirement is mostly fulfilled. Never-
theless, we have noticed two minor inconsistencies. The first, which will be fixed in a subsequent release of
iRefIndex (Ian Donaldson, private communication), involves the PSI-MI labels for interaction detection method
for CORUM interactions and complexes. These are missing from iRefIndex although they are present in the
original CORUM source files. The second issue concerns missing or invalid Pubmed IDs for certain interac-
tions. We found that a number of interactions with missing Pubmed IDs come from MINT. Upon inspection of
the original MINT files, we discovered that in many cases MINT supplies a Digital Object Identifier (DOI) for
a publication as its identifier instead of a Pubmed ID (although the corresponding Pubmed ID can be obtained
from the MINT web interface). To ensure consistency with other source databases within iRefIndex, it would
be desirable to have the Pubmed IDs available for these interactions as well.
In this paper, we have identified the tasks needed for using combined interaction datasets provided by iRe-
fIndex as a basis for construction of reference networks and developed a script to process them into consistent
consolidated datasets. We see ppiTrim as answering a temporary need for a consolidated database and hope
that most of the issues that required processing will be eventually fixed in upstream databases and distributed
through IMEx consortium. At this stage we have not addressed the issue of quality of interactions although
such information is available in some databases for some publications (23). Utilizing the quality information
in consolidating datasets demands a universal data-quality measure that is not yet existent.
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Supplementary Table 1: Description of ppiTrim MITAB 2.6 columns
Column Short Name Description Example
1 uidA Smallest Gene ID of the interactor A∗† entrezgene/locuslink:854647
2 uidB Smallest Gene ID of the interactor B∗ entrezgene/locuslink:855136
3 altA All gene IDs of the interactor A∗ entrezgene/locuslink:854647
4 altB All gene IDs of the interactor B∗ entrezgene/locuslink:855136
5 aliasA All canonical gene symbols and integer
CROGIDs of interactor A
entrezgene/locuslink:BNR1|
icrogid:2105284
6 aliasB All canonical gene symbols and integer
CROGIDs of interactor B
entrezgene/locuslink:MYO5|
icrogid:3144798
7 method PSI-MI term for interaction detection
method
MI:0018(two hybrid)
8 author First author name(s) of the publication in
which this interaction has been shown‡
Tong AH [2002]|tong-2002a-3
9 pmids Pubmed ID(s) of the publication in which
this interaction has been shown
pubmed:11743162
10 taxA NCBI Taxonomy identifier for interactor A taxid:4932(Saccharomyces cerevisiae)
11 taxB NCBI Taxonomy identifier for interactor B taxid:4932(Saccharomyces cerevisiae)
12 interactionType PSI-MI term for interaction type MI:0407(direct interaction)
13 sourcedb PSI-MI terms for source databases‡ MI:0000(MPACT)|MI:0463(grid)|
MI:0465(dip)|MI:0469(intact)
14 interactionIdentifier A list of interaction identifiers? ppiTrim:tyuGkSOK231dh3YnSi6GbczJCFE=|
MPACT:8233|dip:DIP-11198E|grid:147506|
intact:EBI-601565|intact:EBI-601728|
irigid:288990|edgetype:X
15 confidence A list of ppiTrim confidence scores• maxsources:2|dmconsistency:full|
conflicts:S3oaiXt5tA4vVrUsO1rc1TA9krk=
16 expansion Either ‘none’ for binary interactions or ‘bi-
partite’ for subunits of complexes
none
17 biologicalRoleA PSI-MI term(s) for the biological role of in-
teractor A‡
MI:0499(unspecified role)
18 biologicalRoleB PSI-MI term(s) for the biological role of in-
teractor B ‡
MI:0499(unspecified role)
19 experimentalRoleA PSI-MI term(s) for the experimental role of
interactor A‡
MI:0496(bait)|MI:0498(prey)|
MI:0499(unspecified role)
20 experimentalRoleB PSI-MI term(s) for the experimental role of
interactor B‡
MI:0496(bait)|MI:0498(prey)|
MI:0499(unspecified role)
21 interactorTypeA PSI-MI term for the type of interactor A (ei-
ther ‘protein’ or ‘protein complex’)
MI:0326(protein)
22 interactorTypeB PSI-MI term for the type of interactor B (al-
ways ‘protein’)
MI:0326(protein)
29 hostOrganismTaxid NCBI Taxonomy identifier for the host or-
ganism
taxid:4932(Saccharomyces cerevisiae)
31 creationDate Date when ppiTrim was run 2011/05/11
32 updateDate Date when ppiTrim was run 2011/05/11
35 checksumInteraction ppiTrim ID for an interaction ppiTrim:tyuGkSOK231dh3YnSi6GbczJCFE=
36 negative Always ‘false’ false
The above table shows short descriptions for the columns of lines output by ppiTrim with examples. The columns that are not used by
ppiTrim (- output) are omitted. List of items are always separated by the | character (without any intervening spaces). This description
only applies to ppiTrim output; the full PSI-MI 2.6 TAB format description can be found at http://code.google.com/p/psimi/
wiki/PsimiTab26Format Notes: ∗An interactor may be associated with several Gene IDs. In that case the smallest one is written
in uid columns while the entire list is shown in alt columns. †Interactor A may be used to denote a protein complex. In that case
the uidA is of the form complex:<ppiTrim ID>, while altA and aliasA are left empty. ‡Multiple items are possible, originating
from all source records contributing to the consolidated interaction. ?First ID is always the ppiTrim ID for the consolidated interaction,
followed by the original IDs for all contributing interactions and their integer RIGIDs from iRefIndex. The final item is the edge type
code. •maxsources: an estimate of the maximal number of independent experiments contributing to the consolidated interaction;
dmconsistency: consistency of contributing detection method terms. Values are one of invalid (no method terms present), single (only
one method term), min (minimum term found but not maximum), max (maximum term found but not minimum), and full (both minimum
and maximum term present in subcluster); conflicts: ppiTrim IDs of consolidated interactions with detection method term in conflict
with the current one.
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Supplementary Table 2: Remapping of obsolete PSI-MI terms
Original Term Mapped Term Notes
MI:0021 colocalization by fluorescent probes cloning MI:0428 imaging technique
MI:0022 colocalization by immunostaining MI:0428 imaging technique ∗
MI:0023 colocalization/visualisation technologies MI:0428 imaging technique ∗
MI:0025 copurification MI:0401 biochemical
MI:0059 gst pull down MI:0096 pull down
MI:0061 his pull down MI:0096 pull down
MI:0079 other biochemical technologies MI:0401 biochemical
MI:0109 tap tag coimmunoprecipitation MI:0676 tandem affinity purification
MI:0045 experimental interaction detection MI:0492 in vitro †
MI:0493 in vivo MI:0493 in vivo †
MI:0000 coip coimmunoprecipitation MI:0019 coimmunoprecipitation ?
MI:0000 elisa enzyme-linked immunosorbent assay MI:0411 enzyme linked immunosorbent assay ?
∗ Interaction type is also adjusted to MI:0403 as recommended in psi-mi.obo; † HPRD terms are treated as a special case, see main
text; ? MPPI interactions in the human dataset.
Supplementary Table 3: Mapping PTM labels from BioGRID into PSI-MI terms
Original Term Mapped Term
Acetylation MI:0192 acetylation reaction
Deacetylation MI:0197 deacetylation reaction
Demethylation MI:0871 demethylation reaction
Dephosphorylation MI:0203 dephosphorylation reaction
Deubiquitination MI:0204 deubiquitination reaction
Glucosylation MI:0559 glycosylation reaction
Methylation MI:0213 methylation reaction
Nedd(Rub1)ylation MI:0567 neddylation reaction
No Modification MI:0414 enzymatic reaction
Phosphorylation MI:0217 phosphorylation reaction
Prenylation MI:0211 lipid addition
Proteolytic Processing MI:0570 protein cleavage
Ribosylation MI:0557 adp ribosylation reaction
Sumoylation MI:0566 sumoylation reaction
Ubiquitination MI:0220 ubiquitination reaction
Supplementary Table 4: Processing source interactions (RIGIDs)
Species Initial Without Gene ID Retained With Mapped Gene ID
S. cerevisiae 186530 1272 79931 591
H. sapiens 138570 1917 84860 7158
D. melanogaster 46925 4988 39200 2176
Statistics of initial processing of raw interactions from in terms of iRefIndex RIGIDs. A RIGID for an interaction is a unique hash derived
from its interactants’ sequences (with order not significant). Thus, multiple interactions with the same interactants share the same RIGID.
Shown are the initial number, number removed due to missing Gene ID, total number of retained and the number retained containing at
least one interactant with mapped Gene ID. Compared to Table 2 in the main text, this table does not contain a column showing the number
of removed RIGIDs due to filtering criteria. This is becuase the ppiTrim filtering routine operates on raw interactions (corresponding to a
single record from a source database) and some RIGIDs would be associated with both accepted and removed raw interactions.
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Supplementary Table 5: Mapping CROGID identifiers from iRefIndex into Gene IDs: details
Species I V O R P T M G S B
S. cerevisiae 5552 0 0 607 95 461 0 26 21 386
H. sapiens 11428 11 0 2615 155 2017 71 754 429 0
D. melanogaster 7780 0 30 1569 18 814 2 124 440 0
Detailed statistics of mapping CROGIDs into Gene IDs. All numbers denote CROGIDs: directly mapped to valid Gene IDs in the iRefIndex
file (I); directly mapped to Gene IDs but the Gene IDs were updated during validation (V); directly mapped to obsolete Gene IDs (O); not
directly mapped to Gene IDs – total orphans (R); orphans with PDB accession as a primary ID (P); orphans with Uniprot accession as a
primary ID (T); additionally mapped to a valid Gene ID using mapping.txt file from iRefIndex (M); additionally mapped to a valid Gene
ID using a direct reference from Uniprot record (G); additionally mapped to a valid Gene ID using a gene name from Uniprot record (S);
additionally mapped to a Gene ID that was not valid (B).
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Supplementary Table 6: Randomly sampled deflated complexes from high throughput publications
ppiTrim Complex ID Sources Pubmed ID Members Comments
8AVRUHG76vkiFn2cZGICNZzr00Y= grid 14759368 CFT2, YSH1, PTA1,MPE1
Part of mRNA cleavage/polyadenylation com-
plex (4/10 proteins).
9yS57j/gbRbOlNmmimsVeonoraA= grid 14759368 NUT1, MED7, MED4,SIN4, SRB4 Part of mediator complex.
JU+EOkq6ipLh9DJKRtGRLUvT7vM= grid,mint 14759368
UBP6, RPT3, RPN9,
RPT1, RPN8, RPN2,
RPN7, RPN1
Part of proteasome. MINT does not contain
complexes from the original paper.
HtTmhGiPyfIT2vFtRZ94uWw0rsY= grid 16429126
IOC3, HTB1, HTA2,
HHF2, ISW1, KAP114,
ITC1, RPS4A, VPS1,
NAP1, RPO31, ISW2,
TBF1, BRO1, MOT1
Part of Complex # 99.
LnNzfyPGShcG7zkKynU6+fsK2eU= grid 16429126 PSK1, NTH1, BMH2,RTG2, BMH1
Part of complex # 147 (two core proteins plus
three attachments).
S2I6VRjFMWC6rkkM+oYXwKCg9YQ= grid 16429126
RPL4B, MNN10,
MNN11, HOC1, MNN9,
ANP1
Core complex (# 111 – mannan polymerase
II) + one attachment protein (RPL4B).
1fRmAapl2ruoQq202YUJg55maFo= grid,mint 16554755
RSM24, RSM28, MRPS5,
MRP13, MRPS35,
RSM27, RSM7, RSM25,
MRPS17, MRPS12,
RSM19, MRP4
Part of complex # 1.
5tBkYOmK/G1h3vaQmiOnUoBHHMQ= grid,mint 16554755 CFT2, YSH1, MPE1,PAP1 Part of complex # 18.
9f2DVj2rDGeCP53LHOnWRMwq14A= grid,mint 16554755
KAP95, RTT103, VMA2,
RAI1, RAT1, RPB2,
SRP1
True experimental association but not part of
any derived complex.
AVawv51+6Fqe3DquygD/XfyrXxE= grid,mint 16554755
RRP42, RRP45, RRP6,
CSL4, MPP6, RRP4,
LRP1, DDI1
Part of complex # 19.
NOLEwovavMsFrQEdkSUt/mldeMc= grid,mint 16554755 CDC3, SHS1, CDC11,CDC12 Part of complex # 121.
WA51i87Lj1wGp/EeF1OV/YvbW1Y= grid,mint 16554755
GTT2, TRX1, CRN1,
SSA3, IPP1, CMD1,
TRX2, TDH1, RPL40B,
CDC21, OYE2
True experimental association but not part of
any derived complex.
YN/hQXQvzoB5HqrgPzVth28mGsY= grid,mint 16554755
RRP43, RRP42, RRP45,
RRP40, DIS3, RRP6,
RRP4, LRP1
Part of complex # 19.
1LRk+AgI8HpGOSAgkhDzNJWSvtI= grid 20489023
RTG3, RTG2, TOR1,
TOR2, CKA2, MYO2,
MKS1, KOG1
True experimental association.
xWzvxeJFGqjkCihjmQVf5gZhJjQ= dip,grid,mint 20489023
PUF3, SAM1, GCD6,
SPT16, MTC1, YGK3,
LSM12
True experimental association.
To partially investigate the fidelity of deflated complexes of type A and N, we randomly sampled 25 such complexes from the final
ppiTrim yeast dataset and examined the original publications associated with them. This table contains 15 deflated complexes from high-
throughput publications, while Supplemenary Table 7 contains the complexes from low-throughput publications. Most of high-throughput
papers referred to in this table present both the lists of bait-prey associations and of derived complexes. The complexes delated by ppiTrim
are often derived from the former and form only parts of the latter. In the last column of this table, the complex numbers referred to are
labels used by the publication’s authors.
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Supplementary Table 7: Randomly sampled deflated complexes from low-throughput publications
ppiTrim Complex ID Sources Pubmed ID Members Comments
15VfQtoe5gxGNwPSY3AG0sq6A2U= grid 9891041 CCR4, HPR1, PAF1,SRB5, GAL11
NOT a true complex. This is because of bad
annotation of PAF1–SRB5 interaction by the
BioGRID. Completely opposite interpretation
was given in the paper.
d79IdtwfTAENrH8CQ+c8CpS389Y= grid 10329679 YPT1, VPS21, YPT7,GDI1
True complex. This is the only experiment in
the paper.
EtS4cgphEpTqJb/FS5qxyzf0ke8= grid 11733989
CDC39, CCR4, CDC36,
CAF130, CAF40,
CAF120, POP2, NOT5,
MOT2
True complex. CAF120 is an unusual member
that could almost be left out.
2kOyGdwzWywSpN5mhK26gCcC6LQ= grid 14769921
GBP2, IMD3, TEF1,
KEM1, CTK2, CTK1,
CTK3
True complex, except that TEF1 should be
TEF2. This is an error in the iRefIndex source
file; the BioGRID website has the correct as-
signment.
Kd07BBUF07Sqy9NP3D0lixsS/TY= grid 15303280
BUD31, RPL2B, PRP19,
CDC13, ATP1, RPS4A,
SNU114, MDH1,
MAM33, MRPL3,
MRPL17, PRP8, PRP22,
PAB1, BRR2
True association
ZAGz/IZqkEr3/NTDLzPEDAD9cKo= grid 16179952 CDC40, UFD1, SSM4,UBX2
NOT a true complex, probably due to a typo
in annotation. CDC40 cannot be found any-
where in the paper and should most likely be
CDC48.
RDu0dsPAN0QEadfSU5sv05Ifihw= grid 16286007 SIN3, RCO1, RPD3,UME1, EAF3 True complex.
Vqbn3dDwTPgyE9DzbatFNqzdFe0= grid 16615894 VPS36, VPS25, VPS28,SNF8
Vps28 binds the other three, which form a
complex.
lmdypAN9kaHBdasLWS19x8K7KkE= grid 20159987 UBI4, UFD2, PEX29,SSM4
Biological association but indicated as ‘NOT
a stable complex’ in the paper.
aakRh6qVahGxGvqHe399+faxPvA= grid 20655618 PEX13, PEX10, PEX8,PEX12
Association is correct, although mutant strain
was used to obtain this particular complex.
To partially investigate the fidelity of deflated complexes of type A and N, we randomly sampled 25 such complexes from the final ppiTrim
yeast dataset and examined the original publications associated with them. This table contains 10 deflated complexes from low-throughput
publications, while Supplemenary Table 6 contains the complexes from high-throughput publications.
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Supplementary Table 8: Summary of resolvable conflicts
Consolidated terms Count
MI:0018 (two hybrid), MI:0045 (experimental interaction detection), MI:0398 (two hybrid pooling approach), MI:0399
(two hybrid fragment pooling approach)
3959
MI:0090 (protein complementation assay), MI:0111 (dihydrofolate reductase reconstruction) 2612
MI:0090 (protein complementation assay), MI:0112 (ubiquitin reconstruction) 2077
MI:0004 (affinity chromatography technology), MI:0676 (tandem affinity purification) 1840
MI:0004 (affinity chromatography technology), MI:0007 (anti tag coimmunoprecipitation) 1408
MI:0018 (two hybrid), MI:0045 (experimental interaction detection), MI:0397 (two hybrid array) 1231
MI:0018 (two hybrid), MI:0045 (experimental interaction detection) 954
MI:0018 (two hybrid), MI:0397 (two hybrid array) 914
MI:0045 (experimental interaction detection), MI:0686 (unspecified method) 628
MI:0004 (affinity chromatography technology), MI:0019 (coimmunoprecipitation) 598
MI:0018 (two hybrid), MI:0398 (two hybrid pooling approach) 506
MI:0004 (affinity chromatography technology), MI:0007 (anti tag coimmunoprecipitation), MI:0676 (tandem affinity
purification)
444
MI:0018 (two hybrid), MI:0045 (experimental interaction detection), MI:0686 (unspecified method) 320
MI:0004 (affinity chromatography technology), MI:0096 (pull down) 217
MI:0415 (enzymatic study), MI:0424 (protein kinase assay) 192
MI:0045 (experimental interaction detection), MI:0081 (peptide array) 150
MI:0045 (experimental interaction detection), MI:0676 (tandem affinity purification) 120
MI:0492 (in vitro), MI:0493 (in vivo) 5739
MI:0018 (two hybrid), MI:0398 (two hybrid pooling approach) 5394
MI:0018 (two hybrid), MI:0492 (in vitro), MI:0493 (in vivo) 2796
MI:0096 (pull down), MI:0492 (in vitro), MI:0493 (in vivo) 2760
MI:0096 (pull down), MI:0492 (in vitro) 2134
MI:0018 (two hybrid), MI:0492 (in vitro) 1658
MI:0018 (two hybrid), MI:0493 (in vivo) 1193
MI:0018 (two hybrid), MI:0397 (two hybrid array) 1045
MI:0096 (pull down), MI:0493 (in vivo) 513
MI:0004 (affinity chromatography technology), MI:0006 (anti bait coimmunoprecipitation) 384
MI:0004 (affinity chromatography technology), MI:0019 (coimmunoprecipitation) 309
MI:0004 (affinity chromatography technology), MI:0007 (anti tag coimmunoprecipitation) 195
MI:0114 (x-ray crystallography), MI:0492 (in vitro) 166
MI:0004 (affinity chromatography technology), MI:0096 (pull down) 161
MI:0047 (far western blotting), MI:0492 (in vitro), MI:0493 (in vivo) 106
MI:0018 (two hybrid), MI:0398 (two hybrid pooling approach) 17738
MI:0018 (two hybrid), MI:0399 (two hybrid fragment pooling approach) 1426
All resolvable conflicts with counts of more than 100 for yeast (top), human (middle) and fruitfly (bottom) datasets are shown.
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